all report title image

India Advanced Wound Care Management Market Analysis & Forecast: 2025-2032

India Advanced Wound Care Management Market, By Product Type (Wound Dressing, Wound Therapy Devices, Active Wound Care), By Wound Type (Surgical Wounds, Ulcers, Traumatic Wounds, Burns, and others), By End user (Hospitals, clinics, Ambulatory surgical centers, Home care settings, others), By Geography (North India, South India, West India, East India, Central India, and North East India)

  • Published In : Jun 2025
  • Code : CMI3846
  • Pages :220
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

India Advanced Wound Care Management Market Size and Forecast- 2025 to 2032

India Advanced Wound Care Management Market is estimated to be valued at USD 290.5 Mn in 2025 and is expected to reach USD 411.5 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

Key Takeaways

  • By Product type, Wound Dressing segment dominates the market with 40% market share in 2025. This is due to better function, pain, and enhanced quality of life.
  • The North India region is expected to dominate India Advanced Wound Care Management Market with 43.7% market share due to increased agreements.

Market Overview

India's advanced wound care management industry is observing strong growth because of improved awareness about healthcare, the rise in the rate of chronic diseases, and the increasing geriatric population. As technology improves in the medical sector, India is increasingly using state-of-the-art solutions such as hydrocolloids, hydrogels, and collagen dressings, as well as negative pressure wound therapy (NPWT), to manage complex and chronic wounds more effectively. The government's assistance to the healthcare industry, such as programs like the Ayushman Bharat program, is making advanced wound care products more affordable and accessible.

In 2024, firms such as MTF Biologics and Smith & Nephew launched sophisticated biologics-based wound care solutions in India to meet the increasing demand for customized treatments.

Current Events and its Impact

Current Events

Description and its impact

Expansion of Advanced Wound Care Solutions for Diabetic Foot Ulcers

 

  • Description: In 2024, a number of Indian healthcare firms such as Smith & Nephew and ConvaTec broadened their diabetic foot ulcers (DFUs) product offerings, which are a common affliction due to India's growing diabetes incidence. These products consist of advanced dressings, hydrocolloids, and biologics-derived products aimed at accelerating healing and minimizing risks of infection.
  •  Impact: The increase in the incidence of diabetes has necessitated an expanding demand for advanced wound care therapies, especially diabetic foot ulcers. The availability of advanced wound care solutions for DFUs mitigates the risk of amputation and enhances the quality of diabetic patients' lives. The solutions also help decrease healthcare expenses by minimizing the requirement for extended stays in hospitals and repeated medical procedures. As a result, Indian adoption of advanced wound care therapies is on the rise, particularly in the hospital and diabetic clinic setting.

Integration of Telemedicine in Wound Care Management

  • Description: In 2024, some Indian hospitals and clinics started implementing telemedicine platforms with advanced wound care management, which enabled remote monitoring of patients' wounds by medical professionals. The process also involved the use of smart dressings for wounds linked to mobile apps for real-time updates on wound status.
  •  Impact: The use of telemedicine in the management of wounds overcomes issues of healthcare accessibility in rural environments, allowing patients to access timely care and surveillance without the need for long-distance travel. It enhances patient outcomes through constant monitoring and timely intervention where necessary. Moreover, smart dressing use yields useful information to enable informed treatment decisions, minimizing complications and frequent hospital attendance. This is likely to propel the market growth of advanced wound care products, particularly in underdeveloped areas.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Pricing Analysis of India Advanced Wound Care Management Market

The pricing scenario of the advanced wound care management market in India is governed by numerous factors such as the price of raw materials, technological advancements, health infrastructure, and increasing demand for specialized treatments. Advanced wound care products like hydrocolloids, hydrogels, foam dressings, and biologic products are more expensive than conventional wound care products, considering their better healing capabilities and usage of sophisticated materials.

In India, the prices of advanced wound care products may be very different. For instance, simple advanced dressings may cost anywhere between ₹300 to ₹1,500 per unit, whereas more sophisticated products such as collagen-based or biologic dressings may cost anything between ₹3,000 to ₹6,000 per unit. Negative Pressure Wound Therapy (NPWT) machines, which are a high-end product, can cost anywhere between ₹20,000 to ₹50,000 per treatment.

Even with the higher costs, the demand for such sophisticated solutions is on the increase as there is a greater incidence of chronic ailments such as diabetes and a need for effective healing of wounds. Measures by the government, such as Ayushman Bharat and the development of telemedicine and remote monitoring for wound care are also enhancing affordability and accessibility. In general, India's advanced wound care market is experiencing a gradual rise in product uptake, with price-sensitive consumers demanding a balance between efficacy and cost.

Reimbursement Scenario of India Advanced Wound Care Management Market

The reimbursement scenario of advanced wound care management in India is changing, driven mainly by government-backed health insurance programs like Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) and state-run programs like the Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY).

Ayushman Bharat PM-JAY offers health coverage of up to ₹5 lakh per family per year for hospitalization under secondary and tertiary care. Although it covers the gamut of medical procedures, some treatments of complex wounds, particularly those that use costly biologics or complex dressings, might not be covered in the generic packages. This can impact reimbursement for wound care specialist services.

In addition to this, the rates of reimbursement under PM-JAY have also been an issue, with reports stating that the rates for certain procedures are even lower than the costs incurred by hospitals, and thus could affect the viability of offering advanced wound care services. MJPJAY, running in Maharashtra, provides health insurance for different medical interventions. Nevertheless, like with PM-JAY, inclusion of sophisticated wound care procedures within the reimbursement schemes can be limited, with patients having to endure out-of-pocket costs for some specialized wound care procedures.

To meet these challenges, there has been increased focus on incorporating advanced wound care therapies into government reimbursement programs. This is aimed at enhancing the accessibility and affordability of specialized wound care services, especially for chronically ill patients with conditions such as diabetes. Ongoing advocacy and policy changes will be necessary to provide complete coverage for advanced wound care treatment under public health insurance programs in India.

Prescribers’ preference

Lines of Treatment and Prescribing Patterns

Progressive wound care in India adopts a tiered strategy according to the severity, chronicity, and patient comorbidities:

  1. Preventive Care (Stage 0)
  • Emphasis: Prevention of wound formation in high-risk groups (e.g., diabetics).
  • Ordered Interventions:
    • Moisturizing creams: Emollients such as Vaseline® or CutiSoft® to avoid skin breakdown.
    • Protective dressings: Silicone films (e.g., Mepitel®) for friction protection.
    • Patient education: Focus on foot care and glycemic control.
  1. Acute Wound Management (Stage 1–2)
  • Minor abrasions/small burns:
    • Hydrocolloids: DuoDERM® Extra Thin for low exudate.
    • Antimicrobial films: Betadine®-impregnated gauze to prevent infection.
  • Postoperative wounds:
    •  Negative Pressure Wound Therapy (NPWT): KCI V.A.C.® Therapy for more rapid closure.
    • Silver dressings: Acticoat™ Flex 3 to prevent high-risk infection.
  1. Management of Chronic Wounds (Stage 3–4)

Diabetic Foot Ulcers (DFUs)

  • First-line:
    • Alginate dressings: Sorbsan® Calcium Sodium in heavy exudate.
    • Collagen-based products: Promogran® to promote granulation.
  • Refractory cases:
    • NPWT: Altered protocols for offloading (e.g., RENASYS® GO).
    •  Bioengineered skin substitutes: Dermagraft® or AmnioBand® for non-healing ulcers.

Venous Leg Ulcers

  • Compression therapy: As part of
  • Foam dressings: Allevyn® Ag for the control of exudate and odor.
  • Cadexomer iodine: Iodosorb® for disruption of biofilm.
  1. Advanced Interventions
  • Necrotic wounds:
    • Enzymatic debridement: NexoBrid® (approved in India in 2022 for removal of burn eschar).
    • Larval therapy: BioBag® for selective debridement.
  • Infected wounds:
    • Antibiotic-loaded dressings: ColActive® Plus Ag with collagen and silver.

 Factors Influencing Prescriber Preferences

  1. Clinical Efficacy:
  • NPWT use increased by 18% in tertiary care following research that demonstrated a 40% decrease in healing time.
  • Antimicrobial dressings are used in rural areas because of limited availability of sterilization equipment.
  1. Cost Constraints:
  • Hydrocolloids dominate primary care because of low cost (~INR 50–100 per unit).
  • Biosynthetic dressings (e.g., Dermagraft®) are limited to urban areas (costing ~INR 8,000–12,000 per application).
  1. Training Access:
  • 65% of prescribers in metros utilize NPWT compared to 22% in Tier-3 cities, attributed to access to training.
  1. Regulatory Approvals:

- NexoBrid®'s approval in 2022 boosted enzymatic debridement prescriptions by 30% in burn centers.

Brand Preferences by Facility Type

| Facility Type | Preferred Brands | Key Drivers |

| Tertiary Hospitals | KCI V.A.C.®, Dermagraft®, Acticoat™ | Reimbursement, advanced technology |

| Rural Clinics | Betadine® gauze, Sorbsan®, DuoDERM® | Cost efficiency, ease of application |

| Home Healthcare | Allevyn® Ag, Mepilex® Border | Patient compliance, fewer visits |

Regional Prescribing Trends

- Urban Centers: 45% adoption of sophisticated modalities (NPWT, growth factors).

- Rural Areas: 70% use of traditional dressings; antimicrobials developing at 12% CAGR

India Advanced Wound Care Management Market– Driver

  • Growing product approvals

Product launches make an impressive contribution to India's advanced wound care management market, but development in launched products makes an even more impressive contribution to India's Advanced Wound Care Management Market.

For example, In February 2024, Hydrocyn Aqua, an advanced wound care disinfectant developed by Bactiguard, received approval from the Central Drugs Standard Control Organization (CDSCO) in India. This approval paves the way for its commercialization in the Indian market, addressing the growing demand for effective wound care solutions.

India Advanced Wound Care Management Market- Key Trends

The major market players are involved in undergoing inorganic approaches like development in wound care management. From 30th November to 2nd December 2024, AIIMS Bhubaneswar organized WISSEN 2024, the biggest undergraduate medical skills workshop and academic fest of Eastern India. There were various workshops, including clinical case presentations and research paper presentations, which offered a platform for students and professionals to upgrade their knowledge and skill in different medical fields, including wound care.

India Advanced Wound Care Management Market: Restraint

Complications associated with wound care

The rising incidence of Type 2 diabetes in India is a prime cause of complications like diabetic foot ulcers. A pilot project in Thanjavur saw about 10% of diabetic patients develop foot ulcers, putting them at risk for amputations. This prompted the state to increase its "Paadam Kaappom" (Save Feet) programme to implement foot clinics in all government hospitals and conduct training in foot screening and care for health workers.

Segmental Analysis

India Advanced Wound Care Management Market By Product Type

To learn more about this report, Request sample copy

India Advanced Wound Care Management Market insights, by product type

India advanced wound care management market based on product type is categorized into Wound Dressing, Wound Therapy Device, and Active Wound Care. Among which, wound dressing is anticipated to hold maximum market share during the forecast period due to better function, pain, and enhanced quality of life.

India Advanced Wound Care Management Market insights, by wound type

On the basis of wound type, India advanced wound care management market is bifurcated into Surgical Wounds, Ulcers, Traumatic Wound, Burns, and Others. Of which, surgical wound is anticipated to hold the largest share in the market during the forecast period owing to by different uses and technologies.

India Advanced Wound Care Management Market insights, by end user

On the basis of End user, India advanced wound care management market is categorized into Hospitals, clinics, Ambulatory surgical centres, home care settings, and others. Of these, hospitals segment leads the market due to the growth in the number of hospitals and for the rising demand for advanced treatments and surgeries.

India Advanced Wound Care Management Market- Cross sectional analysis

As product base segment, wound dressing dominates from the product type segment. For instance, an article published by the Ministry of Science and Technology on August 6, 2021, explained advanced wound dressing material based on seaweed agar can treat diabetic wounds and manage chronic diseases at a competitive cost. A dressing made of agarose, a natural polymer formed from seaweed agar, is used to treat diabetes patients with infected wounds and those with chronic wounds. This indigenous dressing will make it possible for patients with persistent wounds to have affordable bandages, and it will also open the door to business incubation.

India Advanced Wound Care Management Market- Regional Analysis

The North India region is expected to dominate India Advanced Wound Care Management Market due to increased agreements. Yatharth Hospital & Trauma Care Services Ltd, one of North India's leading private healthcare companies, increased its presence by acquiring the Faridabad-based Asian Fidelis Hospital in a deal worth ₹116 crore and a super-specialty hospital in Delhi for around ₹160 crore. The expansion is with the intent of increasing the reach of superior medical facilities, including specialized wound care therapies, to more patients in the area.

Market Report Scope

India Advanced Wound Care Management Market Report Coverage

Report Coverage Details
Base Year: 2024 Market Size in 2025: USD 290.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.1% 2032 Value Projection: USD 411.5 Mn
Segments covered:
  • By Product Type: Wound Dressing, Wound Therapy Device, Active Wound Care
  • By Wound Type: Surgical Wounds, Ulcers, Traumatic Wound, Burns, Others
  • By End Users: Hospitals, clinics, Ambulatory surgical centers, Home Care Settings ,Others
Companies covered:

Smith and Nephew Plc, Coloplast A/S, Johnson and Johnson, 3M, Convatec Group Plc, Cologenesis Healthcare Pvt Ltd, Mil laboratories Pvt Ltd, Essity AB, Eucare Pharmaceuticals Ltd.

Growth Drivers:
  • Development in launched products 
Restraints & Challenges:
  • Complications associated with wound care

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Key Developments

  • In January 2024, The All-India Institute of Medical Sciences (AIIMS) launched a revolutionary wound healing device that integrates negative pressure therapy and oxygen therapy. This technology marks a major milestone in the management of chronic wounds by providing better healing for patients with complex wounds.
  • In October 2024, MV Hospital for Diabetes, in association with the Academy of Physicians in Wound Healing (United States), commissioned a School of Podiatry by the name of Diabetic Foot Research India. This effort is directed at offering training in podiatric care to medical and paramedical personnel, catering to the increasing demand for specialized wound care skills in India.

Market Segmentation

  • India Advanced Wound Care Management Market, By Product Type:
    • Wound Dressing
      • Foam Dressing
      • Hydrocolloid Dressing
      • Film Dressing
      • Alginate Dressing
      • Collagen Dressing
      • Contact Layer
    • Wound Therapy Devices
      • Pressure Relief Device
      • Negative Pressure Wound Therapy System
      • Hyperbaric Oxygen Equipment
      • Electrical Stimulation Devices
    • Active Wound Care
      • Artificial skin substitute
      • Topical Agents
  • India Advanced Wound Care Management Market, By Wound Type :
    • Surgical Wounds
    • Ulcers
      • Pressure Ulcers
      • Diabetic Foot Ulcers
      • Arterial and venous Ulcers
    • Traumatic Wounds
    • Burns
    • Others
  • India Advanced Wound Care Management Market, By End User:
    • Hospitals
    • clinics
    • Ambulatory surgical centers
    • Home care settings
    • Others
  • India Advanced Wound Care Management Market, By Region:
    • North India
    • South India
    • West India
    • East India
    • Central India
    • North East India
  • Company Overview
    • Smith and Nephew Plc
    • Coloplast A/S
    • Johnson and Johnson
    • 3M
    • Convatec Group Plc
    • Cologenesis Healthcare Pvt Ltd
    • Mil laboratories Pvt Ltd
    • Essity AB
    • Eucare Pharmaceuticals Ltd

Analyst View

The India Advanced Wound Care Management Market is experiencing revolutionary growth fuelled by demographic changes and healthcare advancements. The increased prevalence of diabetes has placed a urgent need for advanced solutions to treat diabetic foot ulcers, which is one of the primary drivers of chronic wound cases. At the same time, India's aging population exacerbates the demand for advanced therapies to treat age-related wounds such as pressure ulcers, especially for long-term care populations.

Technological innovations are transforming paradigms of treatment, with innovations like Negative Pressure Wound Therapy (NPWT) becoming increasingly popular for their ability to speed up healing and minimize complications in complicated wounds. Sophisticated dressings with antimicrobial and moisture-retention capabilities are widely used in outpatient and home settings. Moreover, integration with digital health via telehealth platforms allows for real-time monitoring of wounds, improving compliance with treatment guidelines and minimizing hospital stays.

Avenues exist to increase public-private partnerships to fund subsidization of advanced wound care options and utilize India's increasing medical device manufacturing potential to decrease reliance on imports. The availability of telemedicine and AI-based diagnostic equipment offers untapped opportunities for customized wound management strategies. Geographically, urban centres drive adoption due to infrastructure and familiarity, but rural markets are becoming growth frontiers as healthcare penetration increases.

Sources

Primary Research interviews:

  • Senior Healthcare Administrator at a leading multispecialty hospital in Mumbai
  • Product Manager at a medical device company specializing in advanced wound care
  • Chief Surgeon at a diabetic wound care clinic in Delhi
  • Clinical Research Coordinator at a tertiary care hospital
  • Others

Databases:

  • IMARC Group Medical Devices Industry Data
  • Others

Magazines:

  • Healthcare Executive Magazine India
  • Medical Device News Magazine
  • PharmaTech Outlook India
  • Others

Journals:

  • Indian Journal of Wound Care
  • Journal of Clinical and Diagnostic Research
  • Indian Journal of Plastic Surgery
  • Others

Newspapers:

  • The Hindu BusinessLine (Healthcare Section)
  • The Economic Times (MedTech Coverage)
  • Mint (Hospital Management Reports)
  • Others

Associations:

  • Indian Wound Management Association (IWMA)
  • Association of Surgeons of India (ASI)
  • Federation of Indian Chambers of Commerce & Industry (FICCI) Healthcare Committee
  • Others

Public Domain sources:

  • Indian Ministry of Health and Family Welfare Annual Reports
  • NITI Aayog Healthcare Innovation Publications
  • ResearchAndMarkets.com Public Industry Abstracts
  • Others

Proprietary Elements:

  • CMI Data Analytics Tool
  • Proprietary CMI Existing Repository of information for last 8 years

*Definition  Wound is an injury to living tissue caused by a cut, blow, or other impacts, typically one in which the skin is cut or broken. Traditional wound care and advanced wound care products are two categories of wound care management items. Around the world, traditional wound treatment is more common. In this approach, medical professionals use bandage rolls, dressings, and medical tapes to cover the wound, shield it from the environment, and stop bleeding and infections. Advanced wound care solutions employ foam dressings, alginates, hydrogels, and hydrocolloids to promote natural healing without obstructing the wound.

Share

Share

About Author

Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.

Missing comfort of reading report in your local language? Find your preferred language :

Frequently Asked Questions

The Infertility Devices Market size is estimated to be valued at USD 290.5 Mn in 2025, and is expected to reach USD 411.5 Mn by 2032.

The CAGR of the global Market is projected to be 5.1% from 2025 to 2032.

Increasing prevalence of infertility diseases is expected to drive the market.

Equipment segment is the leading segment in the market.

High cost of the the procedure is expected to hinder the market over the forecast period.

Major players operating in the market include Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD.
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

Select a License Type

Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

US Reciprocal Tax Impact Analysis On India Advanced Wound Care Management Market

Stay updated on tariff changes with expert insights and timely information

© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.